Objectif Since the first cases of AIDS were reported 30 years ago, HIV remains a difficult target for the research field. Although there is no cure for AIDS, HIV infection can be prevented, however in many countries across the world access to prevention and treatment services is limited. Global leaders have pledged to work towards universal access to HIV prevention and care, so that millions of deaths can be averted.There is much that can be done to reduce the impact of AIDS, beginning with the prevention of HIV transmission.In this sense, the main objective of this proposal is to decrease the virus spread avoiding the infection among women. Diminishing HIV transmission among women is a key step towards undermine the virus presence since it will not be transmitted to the new generation of children and to their partners. AIM-HIV project aims to reduce the transmission of HIV in countries with high incidence through the development of a new effective and low-cost microbicide based on 5-Hydroxytyrosol.For this aim, the proposed Consortium will be composed by an SME company with strong research and development capacities and broad experience in the field of hydroxytyrosol, SEPROX Biotech S.L. and three European research groups with a profound knowledge on HIV and cellular HIV infection and integration: Instituto de Salud Carlos III (ISCIII), Commissariat à l’énergie atomique et aux energies alternatives (CEA) and Università Vita-Salute San Raffaele (USR).The duration of the project will be 30 months, with a total budget of 2,331,804€ and a requested grant of 1,827,081€. The estimated EU contribution going to the SME SEPROX is a 25.3% of the total requested EU contribution for the project as a whole.The Consortium has already contacted with organizations and institutions that have a huge interest in the project´s result and will have an important role for assuring the proper dissemination of the final product which will be widely accessible and manage by women themselves Champ scientifique natural sciencesbiological sciencesmicrobiologyvirologymedical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV Programme(s) FP7-HEALTH - Specific Programme "Cooperation": Health Thème(s) HEALTH.2012.2.3.2-3 - Prevention and treatment for HIV/AIDS, malaria and tuberculosis Appel à propositions FP7-HEALTH-2012-INNOVATION-1 Voir d’autres projets de cet appel Régime de financement CP-FP - Small or medium-scale focused research project Coordinateur INSTITUTO DE SALUD CARLOS III Contribution de l’UE € 547 000,80 Adresse MONFORTE DE LEMOS 5 28029 Madrid Espagne Voir sur la carte Région Comunidad de Madrid Comunidad de Madrid Madrid Type d’activité Research Organisations Contact administratif Pedro Cortegoso Fernández (Mr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée Participants (3) Trier par ordre alphabétique Trier par contribution de l’UE Tout développer Tout réduire COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES France Contribution de l’UE € 467 875,85 Adresse RUE LEBLANC 25 75015 PARIS 15 Voir sur la carte Région Ile-de-France Ile-de-France Paris Type d’activité Research Organisations Contact administratif Olivier Leroy (Mr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée UNIVERSITA VITA-SALUTE SAN RAFFAELE Italie Contribution de l’UE € 365 349,55 Adresse VIA OLGETTINA 58 20132 Milano Voir sur la carte Région Nord-Ovest Lombardia Milano Type d’activité Higher or Secondary Education Establishments Contact administratif Maria Rosa Pedrazzi (Dr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée SEPROX BIOTECH SL Espagne Contribution de l’UE € 446 854,80 Adresse CALLE CONDE DE ARANDA 16 1 DERECHA 28001 MADRID Voir sur la carte Type d’activité Private for-profit entities (excluding Higher or Secondary Education Establishments) Contact administratif Yago Romero (Mr.) Liens Contacter l’organisation Opens in new window Site web Opens in new window Coût total Aucune donnée